Recordati Rare Diseases North America
Kelly Macy Satterfield is a Senior Rare Disease/Oncology Key Account Manager with extensive experience in pharmaceutical sales. Kelly has worked with various companies like Recordati Rare Diseases Inc., TerSera Therapeutics, Quintiles, Depomed, Novartis Pharmaceuticals, and Pfizer. Throughout their career, Kelly has successfully launched and sold a range of products in different therapeutic areas and territories. With a background in education from The University of Georgia, Kelly brings a unique combination of skills to their roles in sales and management.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.